HUTCHMED to Announce 2026 Half-Year Financial Results
HUTCHMED (Nasdaq/AIM: HCM; HKEX:13) will announce its 2026 half-year financial results for the six months ended June 30, 2026, on Thursday, July 30, 2026, at 7:00 am EDT / 12:00 noon BST / 7:00 pm HKT.
Rhea-AI Summary
HUTCHMED (Nasdaq/AIM: HCM; HKEX:13) will announce its 2026 half-year financial results for the six months ended June 30, 2026, on Thursday, July 30, 2026, at 7:00 am EDT / 12:00 noon BST / 7:00 pm HKT.
Management will host English and Chinese webcasts with Q&A for analysts and investors, accessible live and via replay on the company website.
Positive
- None.
Negative
- None.
Details
News Market Reaction – HCM
On Jun 30, the day this news came out, HCM closed 0.47% above the previous close.
Data tracked by StockTitan Argus for the Jun 30 session.
Key Figures
- Interim period end
- June 30, 2026
- Six months ended for upcoming half-year financial results
- Results announcement date
- July 30, 2026
- Scheduled release of 2026 half-year interim results
- Results announcement time
- 7:00 am EDT / 12:00 noon BST / 7:00 pm HKT
- Planned publication time of interim results
- English webcast time
- 8:00 am EDT / 1:00 pm BST / 8:00 pm HKT
- Analyst and investor presentation with Q&A
- Chinese webcast time
- 8:30 am HKT, July 31, 2026
- Putonghua webcast for investors and analysts
Previous Earnings date Reports
-
Set date and webcast details for release of 2025 final results.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., June 30, 2026 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM: HCM; HKEX:13) will announce its interim results for the six months ended June 30, 2026 on Thursday, July 30, 2026 at 7:00 am Eastern Daylight Time (EDT) / 12:00 noon British Summer Time (BST) / 7:00 pm Hong Kong Time (HKT).
HUTCHMED management will host two webcast presentations for analysts and investors to discuss the interim results, followed by Q&A sessions. The English webcast will be held on Thursday, July 30, 2026, at 8:00 am EDT / 1:00 pm BST / 8:00 pm HKT. The Chinese (Putonghua) webcast will be held at 8:30 am HKT on Friday, July 31, 2026 (1:30 am BST / 8:30 pm EDT on Thursday, July 30, 2026).
Both webcasts will be available live via the company website at www.hutch-med.com/event/. The presentation will be available to download shortly before the webcast begins. A replay will also be available on the website shortly after the event.
About HUTCHMED
HUTCHMED (Nasdaq/AIM: HCM; HKEX:13) is an innovative, commercial-stage, biopharmaceutical company. It is committed to the discovery and global development and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. Since inception it has focused on bringing drug candidates from in-house discovery to patients around the world, with its first three medicines marketed in China, the first of which is also approved around the world including in the US, Europe and Japan. For more information, please visit: www.hutch-med.com or follow us on LinkedIn.
CONTACTS
| Investor Enquiries | +852 2121 8200 / ir@hutch-med.com |
| Media Enquiries | |
| FTI Consulting – | +44 20 3727 1030 / HUTCHMED@fticonsulting.com |
| Ben Atwell / Tim Stamper | +44 7771 913 902 (Mobile) / +44 7779 436 698 (Mobile) |
| Brunswick – Zhou Yi | +852 9783 6894 (Mobile) / HUTCHMED@brunswickgroup.com |
| Panmure Liberum | Nominated Advisor and Joint Broker |
| Atholl Tweedie / Emma Earl / Rupert Dearden | +44 20 7886 2500 |
| Cavendish | Joint Broker |
| Geoff Nash / Nigel Birks | +44 20 7220 0500 |
| Deutsche Numis | Joint Broker |
| Duncan Monteith / Ramin Naji | +44 20 7545 8000 |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.